活动性狼疮肾炎患儿IgG异常糖基化改变足细胞代谢并导致足细胞损伤
研究从40例儿童系统性红斑狼疮(SLE)及7例健康对照样本中分离IgG,用质谱分析N-聚糖;发现狼疮肾炎(LN)患儿IgG糖基化模式不同于无肾脏受累的SLE患儿,成功治疗后可恢复正常。LN来源IgG处理的足细胞糖酵解速率低于去糖基化LN-IgG或健康IgG处理者,代谢组学显示糖酵解通路富集及五个关键代谢物水平显著不同。
要点
- LN患儿IgG糖基化模式区别于无肾脏受累SLE患儿,成功治疗后趋于正常。
- LN来源IgG处理的足细胞糖酵解速率低于去糖基化LN-IgG或健康IgG处理者。
- LN患者尿中足细胞丙酮酸激酶表达升高,培养足细胞暴露于LN-IgG后PKM水平升高。
核心结论
- LN患儿出现IgG异常糖基化,不良改变足细胞代谢,使足细胞易受损伤。
- 成功治疗可使IgG糖基化逆转至与无肾脏受累SLE患者相当的模式。
- 作者认为这些数据为将IgG糖基化作为LN预测性和药效学生物标志物的大型转化研究奠定了坚实基础。
- 作者认为此工作支持需开发控制LN患者自身靶向IgG异常糖基化的方法,作为减轻足细胞病的机制。
研究设计与样本
- 从40例儿童SLE和7例健康对照样本中分离IgG,用质谱进行N-聚糖分析。
- 通过肽N-糖苷酶F酶处理进行IgG去糖基化,用于足细胞功能研究。
- 对暴露于健康IgG、LN来源IgG或去糖基化LN-IgG的培养足细胞进行非靶向代谢组学,并用代谢物集富集分析。
- 用微滴式数字聚合酶链反应评估尿液细胞和培养足细胞的丙酮酸激酶表达。
主要发现
- LN患儿IgG糖基化模式不同于无肾脏受累的SLE患儿,成功治疗使IgG糖基化正常化。
- LN来源IgG处理的培养足细胞糖酵解速率低于去糖基化LN-IgG或健康志愿者IgG处理的足细胞。
- 足细胞非靶向代谢组学显示糖酵解是LN中富集最明显的通路,并识别出丙酮酸、磷酸烯醇丙酮酸、2-磷酸甘油酸、3-磷酸甘油酸和果糖1,6-二磷酸五个关键代谢物,其水平在LN来源IgG处理足细胞与健康IgG及去糖基化LN-IgG处理足细胞间显著不同。
- 分析还显示围绕由PKM(丙酮酸激酶M)催化的糖酵解限速步骤聚集。
- 尿液分析显示LN患者尿中脱落足细胞的丙酮酸升高且丙酮酸激酶表达高于无肾脏受累SLE患者;培养足细胞暴露于LN-IgG后PKM水平高于非肾脏SLE患者IgG或缓解期LN IgG处理者。
局限性
- 作者指出这些数据为将IgG糖基化作为LN预测性和药效学生物标志物的大型转化研究奠定了基础。
- 作者指出此工作支持需开发控制LN患者自身靶向IgG异常糖基化的方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Podocytes are integral to the maintenance of the glomerular filtration barrier. Their injury results in proteinuria and disease progression in lupus nephritis (LN). Aberrant IgG glycosylation drives podocyte injury in LN and leads to cytoskeletal rearrangement, motility changes, and decreased nephrin production. Based on these findings, we hypothesized that IgG glycosylation patterns differentiate systemic lupus erythematosus (SLE) with and without LN and that this aberrant glycosylation reprograms podocyte metabolism. METHODS: IgG was isolated from 40 pediatric SLE and from 7 healthy control samples. N-glycan analysis was performed using mass spectrometry. IgG deglycosylation was performed through enzymatic treatment by Peptide N-Glycosidase F for functional studies in podocytes. Untargeted metabolomics was performed in cultured podocytes after exposure to healthy IgG, LN-derived IgG, or deglycosylated LN-IgG and analyzed by metabolite set enrichment analysis. Digital droplet polymerase chain reaction was used to evaluate urine cells and podocytes in culture for pyruvate kinase expression. RESULTS: The glycosylation pattern of IgG from children with LN was different from that in children with SLE without kidney involvement. Successful treatment led to normalization of IgG glycosylation. Cultured podocytes treated with LN-derived IgG had a lower rate of glycolysis compared to podocytes incubated with deglycosylated LN-IgG or IgG from healthy volunteers. Untargeted metabolomics of podocytes revealed glycolysis as the most enriched pathway in LN and identified five key metabolites (pyruvic acid, phosphoenolpyruvic acid, 2-phosoglycerate, 3 phosphoglycerate, and fructose 1,6 bisphosphate) in which their levels significantly differed among podocytes exposed to LN-derived IgG (LN-IgG) compared to healthy IgG and deglycosylated LN-IgG. This analysis also revealed clustering around a rate limiting step of glycolysis catalyzed by PKM (Pyruvate Kinase M). Urine analyses revealed elevated pyruvic acid and greater expression of pyruvate kinase in podocytes shed in urine in patients with LN compared to levels in patients with SLE without kidney involvement. Podocytes in culture had elevated PKM levels when exposed to LN-IgG compared to IgG from patients with nonrenal SLE and LN in remission. CONCLUSION: Aberrant IgG glycosylation develops in children with LN and adversely alters podocyte metabolism, rendering these cells vulnerable to injury. Successful treatment reverses IgG glycosylation to patterns comparable to those in patients with nonrenal SLE. These data lay a strong foundation for larger translational studies evaluating the potential of IgG glycosylation as a predictive and pharmacodynamic biomarker for LN. This work also supports a need for the development of approaches to control the aberrant glycosylation of self-targeting IgG in patients with LN as a mechanism to minimize podocytopathy.
引用
- Bhargava R, Upadhyay R, Zhao C, et al. Aberrant Glycosylation of IgG in Children With Active Lupus Nephritis Alters Podocyte Metabolism and Causes Podocyte Injury. Arthritis Rheumatol. 2025. PMID: 40297959. doi:10.1002/art.43200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。